Merck KGaA (MRK) Given a a 116.00 Price Target by Berenberg Bank Analysts


The firm presently has a "buy" rating on the healthcare company's stock. Berenberg Bank's price target suggests a potential upside of 29.46% from the stock's previous close.



from Biotech News